Strategies to adapt adenoviral vectors for targeted delivery.
O'Riordan
Catherine R
CR
Genzyme Corporation, Framingham, MA, USA.
Song
Antonius
A
Lanciotti
Julia
J
D000256:Adenoviridae / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D002213:Capsid / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D004195:Disease Models, Animal; D005260:Female; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007074:Immunoglobulin G / Q000235:genetics / Q000378:metabolism; D051379:Mice; D016513:Mice, SCID; D015394:Molecular Structure; D010051:Ovarian Neoplasms / Q000235:genetics / Q000378:metabolism; D011092:Polyethylene Glycols / Q000737:chemistry / Q000378:metabolism; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism; D011991:Receptors, Virus / Q000378:metabolism; D014161:Transduction, Genetic
C568771:CLMP protein, human; C568772:CLMP protein, mouse; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D007074:Immunoglobulin G; D017468:Receptors, Fibroblast Growth Factor; D011991:Receptors, Virus; D011092:Polyethylene Glycols